Further, comprehensive bioinformatic analyses and functional in vitro experiments display a connection between downregulation of GPC4 and the sensitization of pancreatic cancer cells to chemotherapy [22]. The gene discussed is GPC4; the disease is familial pancreatic carcinoma.